Related references
Note: Only part of the references are listed.Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis
M. D. Sterrenburg et al.
HUMAN REPRODUCTION UPDATE (2011)
Anti-Mullerian Hormone Predicts Menopause: A Long-Term Follow-Up Study in Normoovulatory Women
S. L. Broer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Anti-Mullerian hormone-based prediction model for a live birth in assisted reproduction
A. La Marca et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2011)
Predicting Live Birth, Preterm Delivery, and Low Birth Weight in Infants Born from In Vitro Fertilisation: A Prospective Study of 144,018 Treatment Cycles
Scott M. Nelson et al.
PLOS MEDICINE (2011)
Individual patient data meta-analysis: a promising approach for evidence synthesis in reproductive medicine
Kimiko A. Broeze et al.
HUMAN REPRODUCTION UPDATE (2010)
Deep phenotyping to predict live birth outcomes in in vitro fertilization
Prajna Banerjee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Individual patient data meta-analysis of diagnostic and prognostic studies in obstetrics, gynaecology and reproductive medicine
Kimiko A. Broeze et al.
BMC MEDICAL RESEARCH METHODOLOGY (2009)
The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count
Simtone L. Broer et al.
FERTILITY AND STERILITY (2009)
Cumulative Live-Birth Rates after In Vitro Fertilization
Beth A. Malizia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study
F. Olivennes et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2009)
Systematic Reviews of Diagnostic Test Accuracy
Mariska M. G. Leeflang et al.
ANNALS OF INTERNAL MEDICINE (2008)
The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated basal follicle-stimulating hormone
Richard T. Scott et al.
FERTILITY AND STERILITY (2008)
Elevated day 3 follicle-stimulating hormone/luteinizing hormone ratio ≥ 2 is associated with higher rates of cancellation in in vitro fertilization-embryo transfer cycles
Kimberly E. Liu et al.
FERTILITY AND STERILITY (2008)
The combined effect of age and basal follicle-stimulating hormone on the cost of a live birth at assisted reproductive technology
Melinda B. Henne et al.
FERTILITY AND STERILITY (2008)
The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis
T. E. M. Verhagen et al.
HUMAN REPRODUCTION UPDATE (2008)
Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve
Dharmawijaya N. Lekamge et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2008)
Anti-Mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition
MaryFran R. Sowers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Relationship of serum antimullerian hormone concentration to age at menopause
J. van Disseldorp et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Pituitary suppression regimens in poor responders undergoing IVF treatment: a systematic review and meta-analysis
Sesh Kamal Sunkara et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2007)
Predicting ongoing pregnancy chances after IVF and ICSI: a national prospective study
A. M. E. Lintsen et al.
HUMAN REPRODUCTION (2007)
Does 3D ultrasound offer any advantage in the pretreatment assessment of ovarian reserve and prediction of outcome after assisted reproduction treatment?
K. Jayaprakasan et al.
HUMAN REPRODUCTION (2007)
Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function
David H. Barad et al.
OBSTETRICS AND GYNECOLOGY (2007)
Prediction of ovarian response and IVF/ICSI outcome by three-dimensional ultrasonography and power Doppler angiography
Luis T. Merce et al.
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2007)
Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify patients from attempting in vitro fertilization
Martha Luna et al.
FERTILITY AND STERILITY (2007)
Effect of embryo quality on pregnancy outcome following single embryo transfer in women with a diminished egg reserve
Jerome H. Check et al.
FERTILITY AND STERILITY (2007)
Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology
A. La Marca et al.
HUMAN REPRODUCTION (2007)
Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population
M. McIlveen et al.
HUMAN REPRODUCTION (2007)
Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles - implications for individualization of therapy
Scott M. Nelson et al.
HUMAN REPRODUCTION (2007)
What can the clinician do to improve implantation?
C. M. Boomsma et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2006)
Basal FSH concentration as a predictor of IVF outcome in older women undergoing stimulation with GnRH antagonist
Ettore Caroppo et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2006)
A systematic review of tests predicting ovarian reserve and IVF outcome
F. J. Broekmans et al.
HUMAN REPRODUCTION UPDATE (2006)
Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome
T Eldar-Geva et al.
HUMAN REPRODUCTION (2005)
Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
S Muttukrishna et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2005)
Follicle stimulating hormone as a predictor of ovarian response in women undergoing controlled ovarian hyperstimulation for IVF
M Ashrafi et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2005)
Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment
EHY Ng et al.
HUMAN REPRODUCTION (2005)
Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study
IAJ van Rooij et al.
FERTILITY AND STERILITY (2005)
Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial
ER Klinkert et al.
HUMAN REPRODUCTION (2005)
Obesity and Clomiphene Challenge Test as predictors of outcome of in vitro fertilization and intracytoplasmic sperm injection
ECAM van Swieten et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2005)
Mean ovarian diameter (MOD) as a predictor of poor ovarian response
IK Vladimirov et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2004)
Comparison of basal and clomiphene citrate induced FSH and inhibin B, ovarian volume and antral follicle counts as ovarian reserve tests and predictors of poor ovarian response in IVF
M Erdem et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2004)
Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?
S Muttukrishna et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2004)
Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment: results of a prospective randomized study
J Kwee et al.
HUMAN REPRODUCTION (2003)
A prospective study of predictive factors of ovarian response in 'standard' IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram
B Popovic-Todorovic et al.
HUMAN REPRODUCTION (2003)
Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation
PYK Yong et al.
HUMAN REPRODUCTION (2003)
A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment
B Popovic-Todorovic et al.
HUMAN REPRODUCTION (2003)
Clinical management of low ovarian response to stimulation for IVF: a systematic review
BC Tarlatzis et al.
HUMAN REPRODUCTION UPDATE (2003)
Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve
IAJ van Rooij et al.
HUMAN REPRODUCTION (2002)
Antimullerian hormone serum levels: a putative marker for ovarian aging
A de Vet et al.
FERTILITY AND STERILITY (2002)
A prospective randomized clinical trial of differing starter doses of recombinant follicle-stimulating hormone (follitropin-beta) for first time in vitro fertilization and intracytoplasmic sperm injection treatment cycles
RF Harrison et al.
FERTILITY AND STERILITY (2001)
External validation of the Templeton model for predicting success after IVF
JMJ Smeenk et al.
HUMAN REPRODUCTION (2000)
Basal follicle-stimulating hormone levels are of limited value in predicting ongoing pregnancy rates after in vitro fertilization
LFJMM Bancsi et al.
FERTILITY AND STERILITY (2000)
The significance of the number of antral follicles prior to stimulation in predicting ovarian responses in an IVF programme
EHY Ng et al.
HUMAN REPRODUCTION (2000)